• Atherly Receives RWJ Grant to Study Vermont Community Health Teams
    June 18, 2020
    A new, three-year $500,000 grant from the Robert Wood Johnson Foundation will allow members of the UVM Center for Health Services Research (CHSR) at the Larner College of Medicine, led by center director and Professor of Medicine Adam Atherly, Ph.D., to explore the effectiveness of community health teams in improving the quality and efficiency of health care delivery.
  • Atherly Extensively Quoted in Healthcare Innovation Article
    June 11, 2020
    (JUNE 11, 2020) Adam Atherly, Ph.D., professor of medicine and director of the Center for Health Services Research, is quoted extensively in a Healthcare Innovation article, titled “Are Vermont’s Global Budgets, Community Health Teams Improving Outcomes?”
  • Dean Page Announces 2020 Professionalism Award Recipients
    May 29, 2020
    On May 29, 2020, Dean Richard L. Page, M.D., announced the names of the recipients of the inaugural Dean’s Awards for Professionalism. Jennifer Gilwee, M.D., assistant professor of medicine and chief of of the Division of Internal Medicine, received the Faculty Award for Professionalism. Eric Gagnon, director of facilities administration and projects, received the Staff Award for Professionalism. Isaac de la Bruere, medical student in the Class of 2022, received the Student Award for Professionalism.
  • Class of 2020, Faculty & Staff Accomplishments Celebrated with Online Honors Celebration
    May 12, 2020
    On May 11, awardees from the Larner College of Medicine Class of 2020, faculty and staff were recognized through an online Honors Celebration featuring remarks from Dean Page and videotaped presentations of each award.
  • Dauerman Coauthors Statement on Heart Attack Care During COVID-19 Pandemic
    April 27, 2020
    UVM Professor Harold Dauerman, M.D., and other representatives of the American College of Cardiology, American College of Emergency Physicians and Society of Cardiovascular Angiography & Interventions, issued guidlines to help clinicians make decisions about treatment alternatives for heart attack patients in the environment of the novel coronavirus pandemic.